Hypothesis

The longevity benefits of hormesis depend on a transient but sufficient rise in the NAD+/NADH ratio that drives acetyl-CoA production, thereby enabling CBP/p300‑mediated H3K27ac deposition at stress‑response enhancers. When this metabolic signal crosses a threshold duration, the resulting chromatin mark becomes self‑sustaining through a positive feedback loop involving mitochondrial ROS‑dependent IDH2 activity, which replenishes acetyl‑CoA locally. Stressors that fail to maintain NAD+/NADH elevation long enough produce only transient H3K27ac that is erased after the stimulus ends, explaining why some hormetic interventions yield short‑lived adaptation.

Mechanistic Basis

• NAD+‑dependent activation of SIRT3 increases IDH2 deacetylation, boosting mitochondrial NADPH and citrate export, which fuels cytosolic acetyl‑CoA synthesis via ACLY.
• Elevated acetyl‑CoA raises nuclear H3K27ac at promoters of sod‑3, clt‑1/2 and gpx‑6/7, reinforcing their transcription.
• Sustained H3K27ac recruits BRD4, which keeps RNA polymerase II paused in a poised state, allowing rapid re‑activation upon subsequent stress and stabilizing the epigenetic memory.
• This loop is broken when NAD+/NADH falls, leading to reduced IDH2 activity, lower acetyl‑CoA, and HDAC‑mediated deacetylation.

Testable Predictions

1. Pharmacological inhibition of ATP‑citrate lyase (ACLY) during a hormetic pulse will block lasting H3K27ac accumulation and abolish lifespan extension in C. elegans, even though ROS signaling and Nrf2 activation remain intact.
2. Conversely, boosting acetyl‑CoA via acetate supplementation will rescue the durability of H3K27ac and the longevity benefit of a sub‑threshold hormetic stress.
3. Measuring nuclear acetyl‑CoA levels with a genetically encoded sensor will show a biphasic curve: a sharp rise during stress that persists only when the NAD+/NADH ratio stays above ~1.5 for >6 h in worms or >12 h in human MSCs.

Potential Experiments

• Treat synchronized L1 larvae with 5 mM glucose restriction (a mild hormetic stress) ± 10 µM ACLY inhibitor (SB‑204990). Quantify H3K27ac at sod‑3 by ChIP‑qPCR at 0 h, 6 h, 24 h and 48 h post‑treatment and assess survival curves.
• In human mesenchymal stem cells, expose to 0.5 mM H₂O₂ for 1 h ± 5 mM sodium acetate. Measure NAD+/NADH, acetyl‑CoA (mass spec), H3K27ac at antioxidant promoters, and mitochondrial OCR after 5 days.
• Use CRISPRi to knock down IDH2 in worms; predict loss of persistent H3K27ac despite normal NAD+/NADH spikes.

If ACLY inhibition prevents the epigenetic memory while leaving upstream ROS signaling intact, the hypothesis is supported. If lifespan extension occurs unchanged, the hypothesis is falsified.

References

• https://pmc.ncbi.nlm.nih.gov/articles/PMC12424834/
• https://pmc.ncbi.nlm.nih.gov/articles/PMC10827639/
• https://doi.org/10.1038/s42003-020-01514-y
• https://pmc.ncbi.nlm.nih.gov/articles/PMC4036400/